prof. dr. M.M.R.F. (Michel) Struys
Professor
Telephone:
+31 50 361 5519 (+31503615519)
+31503615519:
+31 50 361 5519 (+31503615519)
m.m.r.f.struys umcg.nl
E-mail:
m.m.r.f.struys umcg.nl
Field/Discipline
Expertise
pharmacokinetics and dynamics, optimisation of drug delivery
Other positions
Head of department Anesthesiology, UMCG
Chair cluster "Acute, Peri-operative and Intensive Care Medicine", UMCG
Director and Board Member British Journal of Anaesthesia (unpaid function)
Chair Scientific Committee, European Society of Anaesthesiology (unpaid function)
Associate Editor Anesthesiology (unpaid function)
Additional Activities: Professor (5%), Department of Basic and Applied Medical Sciences, University Gent, Gent, België
His research group/department received (income for UMCG) (over the last 3 years) research grants and consultancy fees from Masimo (Irvine, CA, USA), Becton Dickinson (Eysins, Switzerland), Fresenius (Bad Homburg, Germany), Paion (Aachen, Germany), Medcaptain Europe (Andelst, The Netherlands), Baxter (Chicago, Il, USA), HanaPharm (Seoul, Republic of Korea).
Former-owner RUGLOOP II (related to my appointment at UGENT as described above)
Recieves royalties on intellectual proporties resulting from research prior to appointment at RUG and UMCG and owned/previously owned by Ghent University and DEMED (in relationship to position at UGENT)
Chair cluster "Acute, Peri-operative and Intensive Care Medicine", UMCG
Director and Board Member British Journal of Anaesthesia (unpaid function)
Chair Scientific Committee, European Society of Anaesthesiology (unpaid function)
Associate Editor Anesthesiology (unpaid function)
Additional Activities: Professor (5%), Department of Basic and Applied Medical Sciences, University Gent, Gent, België
His research group/department received (income for UMCG) (over the last 3 years) research grants and consultancy fees from Masimo (Irvine, CA, USA), Becton Dickinson (Eysins, Switzerland), Fresenius (Bad Homburg, Germany), Paion (Aachen, Germany), Medcaptain Europe (Andelst, The Netherlands), Baxter (Chicago, Il, USA), HanaPharm (Seoul, Republic of Korea).
Former-owner RUGLOOP II (related to my appointment at UGENT as described above)
Recieves royalties on intellectual proporties resulting from research prior to appointment at RUG and UMCG and owned/previously owned by Ghent University and DEMED (in relationship to position at UGENT)
Last modified: | 01 March 2024 12.23 p.m. |